AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Baudax Bio, Inc.

$0 +$0.00 (+900.00%)
OTC · 11 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0 - $0
Year Range
$0$0
Market Cap
4.36K
AVG Volume
3.76K
Trailing/Forward PE
-0/0
PEG ratio
0
Dividend Yield
-
Next Earnings Date
2026-11-11
Primary Exchange
Other OTCUS
Revenue (USD)
0500K1M1.5M20182019202020212022
BXRXQ Revenue (USD) by year
PeriodRevenue (USD)
20221.27M
20211.08M
2020493K
20190
20180
Net Income (USD)
-80M-60M-40M-20M020182019202020212022
BXRXQ Net Income (USD) by year
PeriodNet Income (USD)
2022-58.8M
2021-19.77M
2020-76.1M
2019-32.56M
2018-73.67M
Operating Income (USD)
-80M-60M-40M-20M020182019202020212022
BXRXQ Operating Income (USD) by year
PeriodOperating Income (USD)
2022-23.57M
2021-19.01M
2020-74.79M
2019-43.7M
2018-70.62M
EBITDA (USD)
-80M-60M-40M-20M020182019202020212022
BXRXQ EBITDA (USD) by year
PeriodEBITDA (USD)
2022-46.29M
2021-14.65M
2020-72.19M
2019-46.59M
2018-67.93M
Cash Flows (USD)
-80M-60M-40M-20M020182019202020212022
BXRXQ Cash Flows (USD) by year
PeriodCash Flows (USD)
2022-27.79M
2021-49.47M
2020-44.7M
2019-51.53M
2018-63.12M
EPS (USD)
-15000-10000-5000020182019202020212022
BXRXQ EPS (USD) by year
PeriodEPS (USD)
2022-279.85
2021-545.6
2020-7769.58
2019-5004.31
2018-11361.35
Expenses (USD)
020M40M60M80MR&DSG&ACapex20182019202020212022
BXRXQ Expenses (USD) by year
PeriodExpenses (USD)
202218.1M
202148.64M
202053.06M
201948.56M
201868.29M
Cash & Debt (USD)
010M20M30M40MCashLong Term DebtShort Term Debt20182019202020212022
BXRXQ Cash & Debt (USD) by year
PeriodCash & Debt (USD)
20225.26M
202115.89M
202030.34M
201917.74M
20180
Debt ratios
-0.0200.020.0420212022
BXRXQ Debt ratios by year
PeriodDebt ratios
2022-0.01
20210.04
Margins
-600%-400%-200%0%202020212022
BXRXQ Margins by year
PeriodMargins
2022-451.89%
2021-126.39%
2020-251.32%
Return on Capital
-200%0%200%400%600%20182019202020212022
BXRXQ Return on Capital by year
PeriodReturn on Capital
2022242.54%
2021-149.47%
2020514.22%
2019194.71%
2018107.78%
Shares Outstanding
0200K400K600K800K20182019202020212022
BXRXQ Shares Outstanding by year
PeriodShares Outstanding
2022750.05K
202160.53K
202029.01K
20196.58K
20186.48K
Book Value Per Share (USD)
-15000-10000-50000500020182019202020212022
BXRXQ Book Value Per Share (USD) by year
PeriodBook Value Per Share (USD)
2022-32.32
2021218.5
2020-510.15
2019-2540.41
2018-10540.87
Total Assets (USD)
020M40M60M80M20182019202020212022
BXRXQ Total Assets (USD) by year
PeriodTotal Assets (USD)
202210.03M
202153.28M
202068.73M
201954.21M
201835.02M
Employee Count
0204060802019202020212022
BXRXQ Employee Count by year
PeriodEmployee Count
20229
202180
202057
201924
Free Cash Flow Yield
-200000000%-150000000%-100000000%-50000000%0%med -17923263.36%Jan 25May 25Sep 25Jan 26May 26Sep 26
BXRXQ Free Cash Flow Yield by year
PeriodFree Cash Flow Yield
Sep 26-1792326.39%
Sep 26-1792326.39%
Aug 26-1792326.39%
Aug 26-179232633.63%
Aug 26-1792326.39%
Aug 26-179232633.63%
Jul 26-179232633.63%
Jul 26-1792326.39%
Jul 26-1792326.39%
Jul 26-1792326.39%
Jul 26-1792326.39%
Jun 26-1792326.39%
Jun 26-1792326.39%
Jun 26-1792326.39%
Jun 26-179232633.63%
May 26-1792326.39%
May 26-1792326.39%
May 26-1792326.39%
May 26-1792326.39%
May 26-1792326.39%
Apr 26-1792326.39%
Apr 26-179232633.63%
Apr 26-1792326.39%
Apr 26-1792326.34%
Mar 26-17923263.36%
Mar 26-17923263.36%
Mar 26-17923263.36%
Mar 26-17923263.36%
Feb 26-17923263.36%
Feb 26-179232633.63%
Feb 26-17923263.36%
Feb 26-179232633.63%
Jan 26-17923263.36%
Jan 26-179232633.63%
Jan 26-179232633.63%
Jan 26-17923263.36%
Jan 26-17923263.36%
Dec 25-179232633.63%
Dec 25-17923263.36%
Dec 25-179232633.63%
Dec 25-179232633.63%
Nov 25-17923263.36%
Nov 25-17923263.36%
Nov 25-17923263.36%
Nov 25-17923263.36%
Oct 25-17923263.36%
Oct 25-17923263.36%
Oct 25-17923263.36%
Oct 25-17923263.36%
Oct 25-179232633.63%
Sep 25-17923263.36%
Sep 25-17923263.36%
Sep 25-17923263.36%
Sep 25-179232633.63%
Aug 25-17923263.36%
Aug 25-17923263.36%
Aug 25-179232633.63%
Aug 25-17923263.36%
Aug 25-17923263.36%
Jul 25-17923263.36%
Jul 25-17923263.36%
Jul 25-17923263.36%
Jul 25-17923263.36%
Jun 25-17923263.36%
Jun 25-17923263.36%
Jun 25-17923263.36%
Jun 25-17923263.36%
May 25-17923263.36%
May 25-1792326.34%
May 25-17923263.36%
May 25-17923263.36%
May 25-17923263.36%
Apr 25-17923263.36%
Apr 25-17923263.36%
Apr 25-17923263.36%
Apr 25-17923263.36%
Mar 25-17923263.36%
Mar 25-179232633.63%
Mar 25-17923263.36%
Mar 25-17923263.36%
Feb 25-17923263.36%
Feb 25-17923263.36%
Feb 25-17923263.36%
Feb 25-17923263.36%
Jan 25-17923263.36%
Jan 25-17923263.36%
Jan 25-179232633.63%
Jan 25-17923263.36%
Jan 25-17923263.36%
Dec 24-17923263.36%
Dec 24-179232633.63%
Dec 24-179232633.63%
Dec 24-179232633.63%
Nov 24-1792326.39%
Nov 24-1792326.39%
Nov 24-1792326.39%
Nov 24-1792326.39%
Nov 24-1792326.39%
Oct 24-1792326.34%
Oct 24-896163.19%
Price to Sales
0000.01med 0Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
BXRXQ Price to Sales by year
PeriodPrice to Sales
Sep 260
Sep 260
Aug 260
Aug 260
Aug 260
Aug 260
Jul 260
Jul 260
Jul 260
Jul 260
Jul 260
Jun 260
Jun 260
Jun 260
Jun 260
May 260
May 260
May 260
May 260
May 260
Apr 260
Apr 260
Apr 260
Apr 260
Mar 260
Mar 260
Mar 260
Mar 260
Feb 260
Feb 260
Feb 260
Feb 260
Jan 260
Jan 260
Jan 260
Jan 260
Jan 260
Dec 250
Dec 250
Dec 250
Dec 250
Nov 250
Nov 250
Nov 250
Nov 250
Oct 250
Oct 250
Oct 250
Oct 250
Oct 250
Sep 250
Sep 250
Sep 250
Sep 250
Aug 250
Aug 250
Aug 250
Aug 250
Aug 250
Jul 250
Jul 250
Jul 250
Jul 250
Jun 250
Jun 250
Jun 250
Jun 250
May 250
May 250
May 250
May 250
May 250
Apr 250
Apr 250
Apr 250
Apr 250
Mar 250
Mar 250
Mar 250
Mar 250
Feb 250
Feb 250
Feb 250
Feb 250
Jan 250
Jan 250
Jan 250
Jan 250
Jan 250
Dec 240
Dec 240
Dec 240
Dec 240
Nov 240
Nov 240
Nov 240
Nov 240
Nov 240
Oct 240
Oct 240.01
EV/EBITDA
22.52527.53032.5med 27.15Sep 22Oct 22Oct 22Nov 22Nov 22Dec 22Dec 22
BXRXQ EV/EBITDA by year
PeriodEV/EBITDA
Dec 2223.43
Dec 2223.04
Dec 2226.55
Dec 2225.68
Nov 2226.96
Nov 2226.77
Nov 2227.15
Nov 2229.34
Oct 2229.68
Oct 2228.98
Oct 2230.25
Oct 2230.78
Sep 2231.54
Price to Book
00.20.40.6med 0.28Apr 22May 22Jul 22Aug 22Sep 22Nov 22Dec 22
BXRXQ Price to Book by year
PeriodPrice to Book
Dec 220.1
Dec 220.08
Dec 220.22
Dec 220.19
Nov 220.24
Nov 220.23
Nov 220.24
Nov 220.33
Oct 220.34
Oct 220.32
Oct 220.37
Oct 220.39
Sep 220.42
Sep 220.17
Sep 220.2
Sep 220.22
Sep 220.21
Aug 220.42
Aug 220.47
Aug 220.5
Aug 220.49
Jul 220.46
Jul 220.48
Jul 220.5
Jul 220.57
Jul 220.55
Jun 220.14
Jun 220.14
Jun 220.13
Jun 220.14
May 220.14
May 220.14
May 220.2
May 220.24
Apr 220.28
Apr 220.3
Apr 220.34
Apr 220.33
Apr 220.32
Baudax Bio, Inc.
BXRXQ
Stockpicker

Video analysis: BXRXQ

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.